| Patent |
Priority |
Assignee |
Title |
| 1655158, |
|
|
|
| 2110208, |
|
|
|
| 2168437, |
|
|
|
| 2643653, |
|
|
|
| 3016895, |
|
|
|
| 3025991, |
|
|
|
| 3122162, |
|
|
|
| 3523906, |
|
|
|
| 3538916, |
|
|
|
| 3620216, |
|
|
|
| 3625214, |
|
|
|
| 3632768, |
|
|
|
| 3669104, |
|
|
|
| 3691090, |
|
|
|
| 3732865, |
|
|
|
| 3737337, |
|
|
|
| 3766915, |
|
|
|
| 3773919, |
|
|
|
| 3797492, |
|
|
|
| 3869549, |
|
|
|
| 3891570, |
|
|
|
| 3960757, |
Jun 29 1973 |
Toyo Jozo Co., Ltd. |
Process for encapsulation of medicaments |
| 3987790, |
Oct 01 1975 |
ALZA Corporation |
Osmotically driven fluid dispenser |
| 3995631, |
Jan 13 1971 |
ALZA Corporation |
Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient |
| 3995632, |
Jan 13 1971 |
ALZA Corporation |
Osmotic dispenser |
| 4008719, |
Feb 02 1976 |
ALZA Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent |
| 4034756, |
Jan 13 1971 |
ALZA Corporation |
Osmotically driven fluid dispenser |
| 4078060, |
May 10 1976 |
Richardson-Merrell Inc. |
Method of inducing an estrogenic response |
| 4105030, |
Jan 03 1977 |
American Home Products Corporation |
Implant apparatus |
| 4111201, |
Nov 22 1976 |
ALZA Corporation |
Osmotic system for delivering selected beneficial agents having varying degrees of solubility |
| 4111202, |
Nov 22 1976 |
ALZA Corporation |
Osmotic system for the controlled and delivery of agent over time |
| 4111203, |
Nov 22 1976 |
ALZA Corporation |
Osmotic system with means for improving delivery kinetics of system |
| 4203439, |
Nov 22 1976 |
ALZA Corporation |
Osmotic system with volume amplifier for increasing amount of agent delivered therefrom |
| 4211771, |
Jun 01 1971 |
VIRATEK INC , COVINA, C A DE CORP |
Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide |
| 4221882, |
Jan 31 1979 |
Exxon Research & Engineering Co. |
High impact melt-flowable dual continuum melt mixed polymer blends of polypropylene, polyethylene, and ethylene-propylene rubber |
| 4223674, |
Jun 29 1978 |
Arthur J., McIntosh |
Implant gun |
| 4243030, |
Aug 18 1978 |
Massachusetts Institute of Technology |
Implantable programmed microinfusion apparatus |
| 4305927, |
Apr 08 1976 |
ALZA Corporation |
Method for the management of intraocular pressure |
| 4310516, |
Feb 01 1980 |
SCHWARZ PHARMA, INC |
Cosmetic and pharmaceutical vehicle thickened with solid emulsifier |
| 4340054, |
Dec 29 1980 |
ALZA Corporation |
Dispenser for delivering fluids and solids |
| 4350271, |
Aug 22 1980 |
ALZA CORPORATION, |
Water absorbing fluid dispenser |
| 4373527, |
Apr 27 1979 |
The Johns Hopkins University |
Implantable, programmable medication infusion system |
| 4376118, |
Oct 06 1980 |
Miles Laboratories, Inc. |
Stable nonaqueous solution of tetracycline salt |
| 4384975, |
Jun 13 1980 |
Sandoz, Inc. |
Process for preparation of microspheres |
| 4389330, |
Oct 06 1980 |
ALKERMES CONTROLLED THERAPEUTICS INC II |
Microencapsulation process |
| 4439196, |
Mar 18 1982 |
Merck & Co., Inc. |
Osmotic drug delivery system |
| 4451253, |
Dec 18 1980 |
ENDOCON, INC , A CORP OF MD |
Means and method for administering medicinals |
| 4455143, |
Mar 22 1982 |
ALZA Corporation |
Osmotic device for dispensing two different medications |
| 4455145, |
Jul 10 1981 |
ALZA Corporation |
Dispensing device with internal drive |
| 4474572, |
Sep 29 1981 |
American Home Products Corporation |
Implanting device and implant magazine |
| 4530840, |
Jul 29 1982 |
ALKERMES CONTROLLED THERAPEUTICS INC II |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
| 4552561, |
Dec 23 1982 |
ALZA Corporation |
Body mounted pump housing and pump assembly employing the same |
| 4588614, |
Oct 20 1981 |
Adnovum AG |
Pseudoplastic gel transfer |
| 4594108, |
Sep 19 1983 |
The Dow Chemical Company |
Highly pseudoplastic polymer solutions |
| 4597753, |
Apr 21 1983 |
ROUSSEL-UCLAF S A , A COMPANY OF FRANCE |
Implanting method and device |
| 4609374, |
Apr 22 1985 |
ALZA Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom |
| 4639244, |
May 03 1983 |
ROBINSON, JOHN D , DR , 1830 FOXCROFT LANE, ALLISON PARK, PA 15101 |
Implantable electrophoretic pump for ionic drugs and associated methods |
| 4655462, |
Jan 07 1985 |
BAL SEAL ENGINEERING COMPANY, INC |
Canted coiled spring and seal |
| 4673405, |
Mar 04 1983 |
ALZA Corporation |
Osmotic system with instant drug availability |
| 4675184, |
Nov 28 1981 |
501 Sunstar Kabushiki Kaisha; 502 Toray Industries, Inc. |
Pharmaceutical composition containing interferon in stable state |
| 4695623, |
Apr 15 1983 |
AMGEN INC , A DELAWARE CORPORATION |
Consensus human leukocyte interferon |
| 4727138, |
Jun 20 1985 |
Genentech, Inc. |
Human immune interferon |
| 4734284, |
Feb 19 1985 |
Nippon Kayaku Kabushiki Kaisha |
Etoposide preparations |
| 4743449, |
Sep 12 1983 |
Fujisawa Pharmaceutical Co., Ltd. |
Drug-containing lipid vesicle preparation and method for preparing them |
| 4753651, |
Aug 30 1982 |
ALZA CORPORATION A CORP OF CA |
Self-driven pump |
| 4762791, |
Oct 19 1981 |
Genentech, Inc. |
Human immune interferon |
| 4765989, |
May 11 1983 |
ALZA CORPORATION, A CORP OF DE |
Osmotic device for administering certain drugs |
| 4783337, |
May 11 1983 |
ALZA Corporation |
Osmotic system comprising plurality of members for dispensing drug |
| 4787437, |
Mar 14 1986 |
Stopinc Aktiengesellschaft |
Method for starting a continuous casting plant |
| 4818517, |
Jan 24 1986 |
N V ORGANON |
Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension |
| 4820267, |
Feb 19 1985 |
ENDOCON, INC , A CORP OF MD |
Cartridge injector for pellet medicaments |
| 4820638, |
May 28 1982 |
DR KARL THOMAE GMBH |
Novel alpha interferon species produced by recombinant means |
| 4826144, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Inside back angle canted coil spring |
| 4830344, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Canted-coil spring with turn angle and seal |
| 4834708, |
Mar 31 1987 |
Merit Medical Systems, Inc |
Puncture needle assembly |
| 4840896, |
Nov 02 1983 |
Genzyme Corporation |
Heteropolymeric protein |
| 4845196, |
Jun 24 1985 |
G D SEARLE AND CO , 1751 LAKE COOK RD , DEERFIELD, IL 60015 A CORP OF DE |
Modified interferon gammas |
| 4847079, |
Jul 29 1985 |
Schering Corporation |
Biologically stable interferon compositions comprising thimerosal |
| 4851228, |
Jun 20 1984 |
MERCK & CO , INC , A CORP OF NJ |
Multiparticulate controlled porosity osmotic |
| 4865845, |
Mar 21 1986 |
ALZA Corporation |
Release rate adjustment of osmotic or diffusional delivery devices |
| 4871094, |
Dec 31 1986 |
ALCON MANUFACTURING, LTD |
Means and method for dispensing substances |
| 4873080, |
Jun 08 1983 |
Dr. Karl Thomae GmbH |
Oral anti-diabetic pharmaceutical compositions and the preparation thereof |
| 4874388, |
Jun 25 1987 |
ALZA Corporation |
Multi-layer delivery system |
| 4876781, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Method of making a garter-type axially resilient coiled spring |
| 4882166, |
Sep 30 1981 |
British Technology Group Limited |
Compositions comprising encapsulated particles and their preparation |
| 4885166, |
Jun 11 1985 |
Novartis Corporation |
Hybrid interferons |
| 4886668, |
Sep 24 1987 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic pump |
| 4892778, |
May 27 1987 |
ALZA Corporation |
Juxtaposed laminated arrangement |
| 4893795, |
Aug 15 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Radially loaded canted coiled spring with turn angle |
| 4897471, |
Apr 15 1983 |
AMGEN INC , A DELAWARE CORPORATION |
Consensus human leukocyte interferon |
| 4907788, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Dual concentric canted-coil spring apparatus |
| 4915366, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Outside back angle canted coil spring |
| 4915949, |
Jul 13 1987 |
ALZA Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills |
| 4915954, |
Sep 03 1987 |
ALZA Corporation |
Dosage form for delivering a drug at two different rates |
| 4917887, |
Mar 10 1986 |
Boehringer Ingelheim International GmbH |
Hybrid interferons, their use as pharmaceutical compositions and as intermediate products for the preparation of antibodies and the use thereof and processes for preparing them |
| 4917895, |
Nov 02 1987 |
ALZA Corporation |
Transdermal drug delivery device |
| 4923805, |
Nov 02 1983 |
Genzyme Corporation |
FSH |
| 4927687, |
Oct 01 1984 |
BIOTEK, Inc. |
Sustained release transdermal drug delivery composition |
| 4929554, |
Oct 19 1981 |
|
Human immune interferon |
| 4931285, |
Apr 28 1988 |
ALZA Corporation |
Aqueous based pharmaceutical coating composition for dosage forms |
| 4934666, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Coiled spring electromagnetic shielding gasket |
| 4940465, |
May 27 1987 |
|
Dispenser comprising displaceable matrix with solid state properties |
| 4940588, |
Oct 30 1984 |
Elan Pharma International Limited |
Controlled release powder and process for its preparation |
| 4952402, |
Oct 30 1984 |
Elan Pharma International Limited |
Controlled release powder and process for its preparation |
| 4957119, |
Aug 08 1987 |
ORGANON USA INC |
Contraceptive implant |
| 4961253, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Manufacturing method for canted-coil spring with turn angle and seal |
| 4964204, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Method for making a garter-type axially-resilient coil spring |
| 4969884, |
Dec 28 1988 |
ALZA Corporation |
Osmotically driven syringe |
| 4974821, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Canted-coil spring with major axis radial loading |
| 4976966, |
Dec 29 1988 |
ALZA Corporation |
Delayed release osmotically driven fluid dispenser |
| 4994028, |
Mar 18 1987 |
Endocon, Inc. |
Injector for inplanting multiple pellet medicaments |
| 5004689, |
Feb 22 1982 |
BIOGEN, INC , A CORP OF MA |
DNA sequences, recombinant DNA molecules and processes for producing human gamma interferon-like polypeptides in high yields |
| 5006346, |
Apr 28 1988 |
ALZA Corporation |
Delivery system |
| 5019382, |
Nov 06 1986 |
The Texas A&M University System |
Treatment of immuno-resistant disease with low-dose interferon |
| 5019400, |
May 01 1989 |
ALKERMES CONTROLLED THERAPEUTICS, INC |
Very low temperature casting of controlled release microspheres |
| 5023088, |
Jun 25 1987 |
ALZA Corporation; ALZA CORPORATION, A CORP OF DE |
Multi-unit delivery system |
| 5024842, |
Apr 28 1988 |
ALZA Corporation |
Annealed coats |
| 5030216, |
Dec 15 1989 |
ALZA Corporation |
Osmotically driven syringe |
| 5034229, |
Dec 13 1988 |
ALZA Corporation |
Dispenser for increasing feed conversion of hog |
| 5053014, |
Feb 01 1990 |
MEDEX, INC |
Catheter with controlled valve |
| 5057318, |
Dec 13 1988 |
ALZA Corporation |
Delivery system for beneficial agent over a broad range of rates |
| 5059423, |
Dec 13 1988 |
ALZA Corporation |
Delivery system comprising biocompatible beneficial agent formulation |
| 5066436, |
Jan 04 1989 |
BROCADES PHARMA B V , A CORPORATION OF THE NETHERLANDS |
Process for microencapsulation |
| 5071642, |
Oct 23 1986 |
DR RENTSCHLER GMBH & CO MEDIZIN KG |
Dihydropyridine containing compositions |
| 5072070, |
Dec 01 1989 |
BAL SEAL ENGINEERING COMPANY, INC |
Device for sealing electromagnetic waves |
| 5079388, |
Dec 01 1989 |
BAL SEAL ENGINEERING COMPANY, INC |
Gasket for sealing electromagnetic waves |
| 5090962, |
Apr 28 1989 |
LOKSHOT SA |
Non-reusable syringe |
| 5091188, |
Apr 26 1990 |
PAUL ROYALTY FUND, L P |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 5108078, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Canted-coil spring loaded while in a cavity |
| 5110596, |
Dec 13 1988 |
ALZA Corporation |
Delivery system comprising means for delivering agent to livestock |
| 5112614, |
Sep 14 1989 |
ALZA Corporation |
Implantable delivery dispenser |
| 5113938, |
May 07 1991 |
|
Whipstock |
| 5117066, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Retaining and locking electromagnetic gasket |
| 5118666, |
May 05 1986 |
The General Hospital Corporation |
Insulinotropic hormone |
| 5120306, |
Mar 21 1990 |
|
Direct delivery of anti-inflammatories to the proximal small bowel |
| 5120712, |
May 05 1986 |
The General Hospital Corporation |
Insulinotropic hormone |
| 5120832, |
Aug 27 1984 |
Genentech, Inc. |
Distinct family of human leukocyte interferons |
| 5122128, |
Mar 15 1990 |
ALZA CORPORATION A CORP OF DELAWARE |
Orifice insert for a ruminal bolus |
| 5122377, |
Nov 19 1990 |
Wyeth |
Oral delivery system for veterinary drugs |
| 5126142, |
Jul 18 1989 |
ALZA Corporation |
Dispenser comprising ionophore |
| 5128147, |
Jan 06 1989 |
Thermal Developments, Inc. |
Heat intensifier and localizer for radiofrequency thermotherapy |
| 5134244, |
Apr 25 1988 |
BAL SEAL ENGINEERING COMPANY, INC |
Electromagnetic shielding seal for rotary/reciprocating shaft |
| 5137727, |
Jun 12 1991 |
ALZA Corporation |
Delivery device providing beneficial agent stability |
| 5147295, |
Jan 23 1991 |
NEOGEN CORPORATION |
Retractable implanter |
| 5151093, |
Oct 29 1990 |
DURECT CORPORATION |
Osmotically driven syringe with programmable agent delivery |
| 5160122, |
Mar 20 1990 |
BAL SEAL ENGINEERING COMPANY, INC |
Coil spring with an elastomer having a hollow coil cross section |
| 5160743, |
Apr 28 1988 |
ALZA Corporation |
Annealed composition for pharmaceutically acceptable drug |
| 5161806, |
Dec 17 1990 |
BAL SEAL ENGINEERING COMPANY, INC |
Spring-loaded, hollow, elliptical ring seal |
| 5180591, |
Jul 11 1990 |
ALZA Corporation |
Delivery device with a protective sleeve |
| 5190765, |
Jun 27 1991 |
ALZA Corporation |
Therapy delayed |
| 5192273, |
Jul 24 1989 |
VENETEC INTERNATIONAL, INC |
Catheterization system |
| 5203849, |
Mar 20 1990 |
BAL SEAL ENGINEERING COMPANY, INC |
Canted coil spring in length filled with an elastomer |
| 5204108, |
Oct 10 1987 |
West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited |
Transmucosal formulations of low molecular weight peptide drugs |
| 5207752, |
Mar 30 1990 |
ALZA CORPORATION, A CORPORATION OF DE |
Iontophoretic drug delivery system with two-stage delivery profile |
| 5209746, |
Feb 18 1992 |
ALZA Corporation |
Osmotically driven delivery devices with pulsatile effect |
| 5213809, |
Jan 24 1990 |
ALZA Corporation |
Delivery system comprising means for controlling internal pressure |
| 5213810, |
Mar 30 1990 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same |
| 5219572, |
Mar 17 1989 |
Schering-Plough Animal Health Corporation |
Controlled release delivery device for macromolecular proteins |
| 5221278, |
Mar 12 1992 |
ALZA Corporation |
Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
| 5223265, |
Jan 10 1992 |
ALZA Corporation; ALZA CORPORATION A CORPORATION OF DE |
Osmotic device with delayed activation of drug delivery |
| 5225205, |
Jul 28 1989 |
Debio Recherche Pharmaceutique SA |
Pharmaceutical composition in the form of microparticles |
| 5231176, |
Aug 27 1984 |
Genentech, Inc. |
Distinct family DNA encoding of human leukocyte interferons |
| 5234424, |
Dec 28 1988 |
ALZA Corporation |
Osmotically driven syringe |
| 5234692, |
Jul 11 1990 |
ALZA Corporation |
Delivery device with a protective sleeve |
| 5234693, |
Jul 11 1990 |
ALZA Corporation |
Delivery device with a protective sleeve |
| 5234695, |
Jul 24 1990 |
Eastman Chemical Company |
Water dispersible vitamin E composition |
| 5250026, |
May 27 1992 |
Digital Angel Corporation |
Adjustable precision transponder injector |
| 5252338, |
Jun 27 1991 |
ALZA Corporation |
Therapy delayed |
| 5260069, |
Nov 27 1992 |
BANK OF AMERICA, N A , AS AGENT |
Pulsatile particles drug delivery system |
| 5278151, |
Apr 02 1987 |
Ocular Research of Boston, Inc. |
Dry eye treatment solution |
| 5279544, |
Mar 13 1992 |
Elan Pharma International Limited |
Transdermal or interdermal drug delivery devices |
| 5279554, |
Feb 09 1990 |
Merial |
Implanting device |
| 5279555, |
Aug 24 1992 |
Merck & Co., Inc.; MERCK & CO , INC |
Device for injecting implants |
| 5279608, |
Dec 18 1990 |
Societe de Conseils de Recherches et d'Applications Scientifiques |
Osmotic pumps |
| 5284655, |
Aug 27 1990 |
Warsaw Orthopedic, Inc |
Swollen demineralized bone particles, flowable osteogenic composition containing same and use of the composition in the repair of osseous defects |
| 5288501, |
Jul 04 1991 |
MERZ PHARMA GMBH & CO KGAA |
Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients |
| 5288502, |
Oct 16 1991 |
Board of Regents, The University of Texas System |
Preparation and uses of multi-phase microspheres |
| 5290271, |
May 14 1990 |
DERMAGENESIS, LLC |
Surgical implant and method for controlled release of chemotherapeutic agents |
| 5300079, |
Jan 30 1991 |
Texas Instruments Incorporated |
Injector |
| 5300302, |
Oct 04 1990 |
Nestec S.A. |
Pharmaceutical composition in gel form in a dispensing package |
| 5308348, |
Feb 18 1992 |
ALZA Corporation |
Delivery devices with pulsatile effect |
| 5312335, |
Nov 09 1989 |
BIOJECT INC , AN OR CORP |
Needleless hypodermic injection device |
| 5312389, |
Oct 29 1990 |
DURECT CORPORATION |
Osmotically driven syringe with programmable agent delivery |
| 5312390, |
Jan 10 1992 |
ALZA Corporation |
Osmotic device with delayed activation of drug delivery |
| 5318558, |
Mar 12 1992 |
ALZA Corporation |
Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
| 5318780, |
Oct 30 1991 |
MDV TECHNOLOGIES, INC |
Medical uses of in situ formed gels |
| 5320616, |
Dec 13 1988 |
ALZA Corporation |
Delivery system comprising first walled section and second walled section united by fusion, adhesion or telescopic engagement |
| 5324280, |
Apr 02 1990 |
ALZA Corporation |
Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
| 5336057, |
Sep 30 1991 |
Nippon Densan Corporation |
Micropump with liquid-absorptive polymer gel actuator |
| 5336505, |
Aug 28 1989 |
PHARMACEUTICAL DELIVERY SYSTEM |
Bioerodible polymers useful for the controlled release of therapeutic agents |
| 5348544, |
Nov 24 1993 |
Becton, Dickinson and Company |
Single-handedly actuatable safety shield for needles |
| 5352662, |
Oct 01 1991 |
Eli Lilly and Company |
Injectable extended release formulations and methods |
| 5368588, |
Feb 26 1993 |
|
Parenteral fluid medication reservoir pump |
| 5368863, |
Jan 24 1990 |
ALZA Corporation |
Long-term delivery device with early startup |
| 5371089, |
Feb 26 1987 |
Senetek, PLC |
Method and composition for ameliorating the adverse effects of aging |
| 5374620, |
Jun 07 1990 |
Genentech, Inc |
Growth-promoting composition and its use |
| 5385738, |
Oct 14 1983 |
Sumitomo Pharmaceuticals Company, Ltd. |
Sustained-release injection |
| 5385887, |
Sep 10 1993 |
Genetics Institute, LLC |
Formulations for delivery of osteogenic proteins |
| 5395319, |
Mar 06 1991 |
Suddeutsche Feinmechanik GmbH |
Needle for inserting an object into the body |
| 5407609, |
May 04 1989 |
BROOKWOOD PHARMACEUTICALS, INC |
Microencapsulation process and products therefrom |
| 5411951, |
Oct 04 1984 |
Eli Lilly and Company |
Prolonged release of biologically active somatotropin |
| 5413572, |
Apr 02 1990 |
ALZA Corporation |
Osmotic dosage system for liquid drug delivery |
| 5413672, |
Jul 22 1992 |
MFM TECHNOLOGY, L L C |
Method of etching sendust and method of pattern-etching sendust and chromium films |
| 5424286, |
May 24 1993 |
|
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same |
| 5428024, |
Feb 28 1992 |
Allergan, Inc |
High concentration homogenized collagen compositions |
| 5429602, |
Apr 29 1992 |
|
Programmable portable infusion pump system |
| 5439688, |
Jul 20 1990 |
DEBIO RECHERCHE PHARMACEUTIQUE S A |
Process for preparing a pharmaceutical composition |
| 5443459, |
Jan 30 1991 |
ALZA Corporation |
Osmotic device for delayed delivery of agent |
| 5445829, |
May 05 1989 |
Drugtech Corporation |
Extended release pharmaceutical formulations |
| 5456679, |
Feb 18 1992 |
ALZA Corporation |
Delivery devices with pulsatile effect |
| 5458888, |
Mar 02 1994 |
BANK OF AMERICA, N A , AS AGENT |
Controlled release tablet formulation |
| 5464929, |
Mar 06 1995 |
Ethicon, Inc. |
Absorbable polyoxaesters |
| 5472708, |
Nov 27 1992 |
BANK OF AMERICA, N A , AS AGENT |
Pulsatile particles drug delivery system |
| 5478564, |
Feb 22 1990 |
Teva Pharmaceutical Industries Ltd |
Preparation of microparticles for controlled release of water-soluble substances |
| 5484403, |
Apr 05 1994 |
AVID IDENTIFICATION SYSTEMS, INC |
Hypodermic syringe for implanting solid objects |
| 5486365, |
Sep 17 1993 |
DOW CORNING ENTERPRISES, INC AS COLLATERAL AGENT |
Calcium hydrogen phosphate, a method for preparing it, and an excipient utilizing it |
| 5498255, |
Aug 17 1993 |
ALZA Corporation |
Osmotic device for protracted pulsatile delivery of agent |
| 5511355, |
Apr 06 1992 |
|
Construction element |
| 5512293, |
Jul 23 1992 |
ALZA Corporation |
Oral sustained release drug delivery device |
| 5512549, |
Oct 18 1994 |
Eli Lilly and Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 5514110, |
Mar 22 1993 |
|
Automatic flow control device |
| 5529914, |
Aug 05 1991 |
BOARD OF REGENTS, THE |
Gels for encapsulation of biological materials |
| 5531736, |
Jan 30 1991 |
ALZA Corporation |
Osmotic device for delayed delivery of agent |
| 5540665, |
Jan 31 1994 |
ALZA Corporation |
Gas driven dispensing device and gas generating engine therefor |
| 5540912, |
Mar 30 1993 |
ALZA Corporation |
Viscous suspensions of controlled-release drug particles |
| 5541172, |
Jun 28 1991 |
Endorecherche, Inc. |
Controlled release systems and low dose androgens |
| 5542682, |
Mar 27 1995 |
TI SPECIALTY POLYMER PRODUCTS, INC |
Slant coil spring and seal |
| 5543156, |
Jan 09 1991 |
ALZA Corporation |
Bioerodible devices and compositions for diffusional release of agents |
| 5545618, |
Sep 20 1991 |
SCIOS, INC |
GLP-1 analogs useful for diabetes treatment |
| 5556642, |
Jul 16 1992 |
Tanabe Seiyaku Co., Ltd. |
Method for producing sustained release microsphere preparation |
| 5557318, |
Jul 12 1994 |
Koninklijke PTT Nederland N.V. |
Method and apparatus for permitting a viewer to scan through a plurality of video signals provided by a transmitter |
| 5558637, |
Oct 13 1993 |
Leiras Oy |
Implant injection device |
| 5569289, |
Jun 24 1993 |
|
Safety penetrating instrument with penetrating member and cannula moving during penetration and triggered safety member protusion |
| 5571525, |
Mar 30 1993 |
DURECT CORPORATION |
Erosion rate modifier for use in bioerodible drug delivery devices and method of use |
| 5574008, |
Aug 30 1994 |
Eli Lilly and Company |
Biologically active fragments of glucagon-like insulinotropic peptide |
| 5574137, |
Dec 16 1983 |
Genentech, Inc. |
Recombinant gamma interferons having enhanced stability and methods therefor |
| 5580578, |
Jan 27 1992 |
Purdue Pharma LP |
Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| 5589167, |
Feb 23 1993 |
Genentech, Inc. |
Excipient stabilization of polypeptides treated with organic solvents |
| 5595751, |
Mar 06 1995 |
Ethicon, Inc.; Ethicon, Inc |
Absorbable polyoxaesters containing amines and/or amido groups |
| 5595759, |
Nov 10 1994 |
ALZA Corporation |
Process for providing therapeutic composition |
| 5597579, |
Mar 06 1995 |
Ethicon, Inc.; Ethicon, Inc |
Blends of absorbable polyoxaamides |
| 5602010, |
Dec 10 1986 |
Boehringer Ingelheim International GmbH |
DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides |
| 5605688, |
Aug 16 1985 |
Boehringer Ingelheim International GmbH |
Recombinant dog and horse type I interferons |
| 5607687, |
Mar 06 1995 |
Ethicon, Inc.; Ethicon, Inc |
Polymer blends containing absorbable polyoxaesters |
| 5609885, |
Sep 15 1992 |
ALZA Corporation |
Osmotic membrane and delivery device |
| 5613954, |
Nov 21 1994 |
Stryker Corporation |
Laparoscopic surgical Y-tube cannula |
| 5614221, |
Oct 23 1989 |
Medivent |
Method of preparing a drug delivery system comprising a drug and a gel using a syringe |
| 5614492, |
May 05 1986 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof |
| 5618552, |
Mar 06 1995 |
Ethicon, Inc.; Ethicon, Inc |
Absorbable polyoxaesters |
| 5620698, |
Mar 06 1995 |
Ethicon, Inc. |
Blends of absorbable polyoxaesters containing amines and/or amido groups |
| 5620705, |
Aug 04 1994 |
Encinal Pharmaceutical Investments, LLC |
Progestin tablet |
| 5630796, |
Apr 08 1993 |
Powderject Research Limited |
Method of delivering powder transdermally with needless injector |
| 5633011, |
Aug 04 1994 |
Encinal Pharmaceutical Investments, LLC |
Progesterone replacement therapy |
| 5635213, |
Nov 30 1992 |
ABBVIE B V |
Pharmaceutical formulation |
| 5639477, |
Jun 23 1993 |
ALZA Corporation |
Ruminal drug delivery device |
| 5639640, |
Nov 02 1983 |
Genzyme Corporation |
DNA encoding the beta subunit of human follide stimulating hormone and expression vectors and cells containing same |
| 5645850, |
Mar 06 1995 |
Ethicon, Inc. |
Blending containing absorbable polyoxaamides |
| 5648088, |
Mar 06 1995 |
Ethicon, Inc.; Ethicon, Inc |
Blends of absorbable polyoxaesters containing amines and/or amide groups |
| 5650173, |
Nov 19 1993 |
ALKERMES, INC |
Preparation of biodegradable microparticles containing a biologically active agent |
| 5654008, |
Nov 19 1993 |
ALKERMES, INC |
Preparation of biodegradable microparticles containing a biologically active agent |
| 5654010, |
Dec 02 1992 |
ALKERMES CONTROLLED THERAPEUTICS, INC |
Composition for sustained release of human growth hormone |
| 5656297, |
Mar 12 1992 |
ALKERMES CONTROLLED THERAPEUTICS, INC 64 SIDNEY STREET |
Modulated release from biocompatible polymers |
| 5656299, |
Nov 17 1992 |
REEDHYCALOG, L P |
Sustained release microsphere preparation containing antipsychotic drug and production process thereof |
| 5658593, |
Jan 16 1992 |
Coletica |
Injectable compositions containing collagen microcapsules |
| 5660847, |
Sep 14 1989 |
ALZA Corporation |
Implantable delivery dispenser comprising exit port |
| 5660858, |
Apr 03 1996 |
Jagotec AG |
Cyclosporin emulsions |
| 5660861, |
Apr 18 1994 |
ALZA Corporation |
Effective therapy for epilepsies |
| 5667808, |
Dec 02 1992 |
ALKERMES CONTROLLED THERAPEUTICS, INC |
Composition for sustained release of human growth hormone |
| 5668170, |
Jul 13 1994 |
ALZA Corporation |
Composition and method enhancing transdermal electrotransport agent delivery |
| 5672549, |
Jan 31 1996 |
Sumitomo Bakelite Company Limited |
Method of producing epoxy resin-encapsulated semiconductor device |
| 5676942, |
Feb 10 1992 |
HEMISPHERX BIOPHARMA, INC |
Composition containing human alpha interferon species proteins and method for use thereof |
| 5686097, |
Sep 29 1993 |
ALZA Corporation |
Monoglyceride/lactate ester permeation enhancer for codelivery of steroids |
| 5688801, |
Nov 19 1993 |
ALKERMES, INC |
Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 5690925, |
Dec 16 1983 |
Genentech, Inc. |
Recombinant gamma interferons having enhanced stability and methods therefor |
| 5690952, |
Jun 07 1995 |
ALZA Corporation |
Implantable system for delivery of fluid-sensitive agents to animals |
| 5695463, |
Sep 27 1994 |
IPSEN PHARMA S A S |
Safety injection device |
| 5697914, |
Mar 16 1995 |
Becton Dickinson and Company |
Control forward/flashback forward one hand introducer needle and catheter assembly |
| 5698213, |
Mar 06 1995 |
Ethicon, Inc |
Hydrogels of absorbable polyoxaesters |
| 5700486, |
Nov 22 1990 |
APTALIS PHARMATECH, INC |
Pharmaceutical compositions in the form of particles suitable for the controlled release of pharmacologically active substances and process for preparing the same compositions |
| 5700583, |
Mar 06 1995 |
Ethicon, Inc |
Hydrogels of absorbable polyoxaesters containing amines or amido groups |
| 5703200, |
Mar 15 1996 |
Ethicon, Inc. |
Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer |
| 5707644, |
Nov 04 1989 |
West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited |
Small particle compositions for intranasal drug delivery |
| 5711967, |
Jun 17 1991 |
Spirig AG, Pharmazeutische Praeparate |
Oral diclofenac preparation |
| 5713847, |
Nov 01 1994 |
The University of Iowa Research Foundation |
Human drug delivery device for tinnitus |
| 5718922, |
May 31 1995 |
Schepens Eye Research Institute, Inc. |
Intravitreal microsphere drug delivery and method of preparation |
| 5725497, |
Jun 07 1995 |
American Cyanamid Company |
Injection dart system |
| 5728088, |
Dec 13 1988 |
ALZA Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals |
| 5728396, |
Feb 02 1996 |
INTARCIA THERAPEUTICS, INC |
Sustained delivery of leuprolide using an implantable system |
| 5733572, |
Dec 22 1989 |
IMARX THERAPEUTICS, INC |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| 5736159, |
Apr 28 1995 |
BANK OF AMERICA, N A , AS AGENT |
Controlled release formulation for water insoluble drugs in which a passageway is formed in situ |
| 5738845, |
Mar 02 1989 |
WOMEN S RESEARCH INSTITUTE, THE |
Human interferon τ proteins and methods of use |
| 5747058, |
Jun 07 1995 |
DURECT CORPORATION |
High viscosity liquid controlled delivery system |
| 5756450, |
Sep 15 1987 |
Novartis Corporation |
Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms |
| 5767251, |
Jan 30 1985 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
| 5770231, |
Nov 19 1993 |
ALKERMES, INC |
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles |
| 5782396, |
Aug 28 1995 |
Tyco Healthcare Group LP |
Surgical stapler |
| 5792477, |
May 02 1997 |
ALKERMES, INC |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent |
| 5795591, |
Oct 10 1991 |
ALZA Corporation |
Osmotic drug delivery devices with hydrophobic wall materials |
| 5795779, |
Nov 01 1982 |
Berlex Laboratories, Inc.; Leland Stanford Junior University |
Human interferon-β (IFN-β) produced in Chinese hamster ovary (CHO) cells |
| 5807876, |
Apr 23 1996 |
VERTEX PHARMACEUTICALS INCORPORATED |
Inhibitors of IMPDH enzyme |
| 5810769, |
Feb 25 1994 |
Suddeutsche Feinmechanik GmbH |
Cannula for the subcutaneous deposition of an object |
| 5814323, |
Oct 16 1995 |
Lever Brothers Company, Division of Conopco, Inc. |
Cosmetic composition |
| 5817129, |
Oct 31 1996 |
Ethicon, Inc |
Process and apparatus for coating surgical sutures |
| 5827297, |
Oct 01 1992 |
Medicamat S.A. |
Device for transplanting small diameter hair grafts |
| 5830501, |
Dec 06 1991 |
ALZA Corporation |
Dosage form comprising hydrophilic polymer |
| 5836935, |
Nov 10 1994 |
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE |
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body |
| 5843891, |
Apr 28 1993 |
|
Pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug |
| 5844017, |
Mar 06 1995 |
Ethicon, Inc |
Prepolymers of absorbable polyoxaesters containing amines and/or amido groups |
| 5851451, |
Dec 15 1995 |
Takeda Pharmaceutical Company, Limited |
Production of microspheres |
| 5858746, |
Apr 20 1992 |
Board of Regents, The University of Texas System |
Gels for encapsulation of biological materials |
| 5859150, |
Mar 06 1995 |
Ethicon, Inc |
Prepolymers of absorbable polyoxaesters |
| 5861166, |
Mar 12 1991 |
ALZA Corporation |
Delivery device providing beneficial agent stability |
| 5871770, |
Jun 07 1995 |
ALZA Corporation |
Implantable system for delivery of fluid-sensitive agents to animals |
| 5871778, |
Nov 17 1992 |
Mitsubishi Pharma Corporation |
Sustained release microsphere preparation containing antipsychotic drug |
| 5874388, |
Apr 02 1997 |
Dow Corning Corporation |
Lubricant composition for disc brake caliper pin and a disc brake asembly containing the lubricant |
| 5876746, |
Jun 07 1995 |
Ortho-McNeil Pharmaceutical, Inc |
Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 5882676, |
May 26 1995 |
ALZA Corporation |
Skin permeation enhancer compositions using acyl lactylates |
| 5904935, |
Jun 07 1995 |
INTARCIA THERAPEUTICS, INC |
Peptide/protein suspending formulations |
| 5906599, |
Nov 09 1995 |
INTERMED, INC |
Device for delivering biological agents |
| 5906816, |
Mar 16 1995 |
University of Florida |
Method for treatment of autoimmune diseases |
| 5906830, |
Sep 08 1995 |
Ortho-McNeil Pharmaceutical, Inc |
Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
| 5908621, |
Nov 02 1995 |
Merck Sharp & Dohme Corp |
Polyethylene glycol modified interferon therapy |
| 5916598, |
May 07 1996 |
ALKERMES, INC |
Preparation of biodegradable, biocompatible microparticles containing a biologically active agent |
| 5922253, |
May 18 1995 |
ALKERMES CONTROLLED THERAPEUTICS, INC, |
Production scale method of forming microparticles |
| 5928666, |
Nov 12 1996 |
Ortho-McNeil Pharmaceutical, Inc |
Crystalline form of estradiol and pharmaceutical formulations comprising same |
| 5932547, |
Jun 13 1997 |
HORATIO WASHINGTON DEPOT TECHNOLOGIES LLC |
Non-aqueous polar aprotic peptide formulations |
| 5938654, |
Jun 25 1987 |
ALZA Corporation |
Osmotic device for delayed delivery of agent |
| 5939286, |
May 10 1995 |
FLORIDA, UNIVERSITY OF, A FLORIDA CORPORATION |
Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them |
| 5942223, |
Mar 02 1989 |
WOMENS S RESEARCH INSTITUTE, THE |
Antiviral therapy using ovine or bovine interferon-tau |
| 5942253, |
Oct 12 1995 |
ALCAFLEU MANAGEMENT GMBH & CO KG |
Prolonged release of GM-CSF |
| 5945126, |
Feb 13 1997 |
OAKWOOD LABORATORIES L L C , A DELAWARE LIMITED LIABILITY CORPORATION |
Continuous microsphere process |
| 5948430, |
Nov 11 1996 |
LTS Lohmann Therapie-Systeme GmbH |
Water soluble film for oral administration with instant wettability |
| 5951521, |
Sep 25 1998 |
MEDTRONIC MINIMED, INC |
Subcutaneous implantable sensor set having the capability to remove deliver fluids to an insertion site |
| 5958909, |
May 05 1986 |
The General Hospital Corporation |
Insulinotropic hormones and uses thereof |
| 5962023, |
Mar 06 1995 |
Ethicon, Inc |
Hydrogels containing absorbable polyoxaamides |
| 5965168, |
Nov 19 1993 |
ALKERMES, INC |
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 5972370, |
Jun 07 1995 |
INTARCIA THERAPEUTICS, INC |
Peptide/protein suspending formulations |
| 5972373, |
May 02 1995 |
Taisho Pharmaceutical Co., Ltd. |
Taste masking pharmaceutical composition for oral administration |
| 5976109, |
Apr 30 1996 |
Medtronic, Inc |
Apparatus for drug infusion implanted within a living body |
| 5980945, |
Jan 16 1996 |
IPSEN PHARMA S A S |
Sustained release drug formulations |
| 5981719, |
Mar 09 1993 |
Baxter International Inc; BAXTER HEALTHCARE SA A CORPORATION OF SWITZERLAND |
Macromolecular microparticles and methods of production and use |
| 5984890, |
Sep 27 1996 |
Wyeth |
Medical device for the placement of solid materials |
| 5985305, |
Feb 02 1996 |
INTARCIA THERAPEUTICS, INC |
Sustained delivery of an active agent using an implantable system |
| 5989463, |
Sep 24 1997 |
ALKERMES CONTROLLED THERAPEUTICS, INC |
Methods for fabricating polymer-based controlled release devices |
| 5997527, |
Mar 24 1997 |
INTARCIA THERAPEUTICS, INC |
Self adjustable exit port |
| 5997902, |
Jun 23 1993 |
ALZA Corporation |
Ruminal drug delivery device |
| 6007805, |
Mar 07 1994 |
Imperial College of Science and Technology |
Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver |
| 6017545, |
Feb 10 1998 |
GENEREX PHARMACEUTICALS INC |
Mixed micellar delivery system and method of preparation |
| 6022561, |
Feb 04 1994 |
LIPOCORE HOLDING AB |
Bilayers preparations |
| 6029361, |
Mar 25 1998 |
ULTRATECH, INC |
Air-guage nozzle probe structure for microlithographic image focusing |
| 6053927, |
Oct 15 1998 |
RSH-GS Trust |
Apparatus and method for implant removal |
| 6056718, |
Mar 04 1998 |
MEDTRONIC MINIMED, INC |
Medication infusion set |
| 6060450, |
Mar 16 1995 |
University of Florida |
Method for treatment of autoimmune diseases |
| 6069133, |
Mar 14 1996 |
IMMUNE RESPONSE CORPORATION, THE |
Targeted delivery of genes encoding interferon |
| 6074377, |
Oct 10 1996 |
|
Method of installing vascular access device |
| 6074660, |
Apr 20 1998 |
Ethicon, Inc |
Absorbable polyoxaesters containing amines and/ or amido groups |
| 6074673, |
Apr 22 1996 |
|
Slow-release, self-absorbing, drug delivery system |
| 6100346, |
Mar 06 1995 |
Ethicon, Inc |
Copolymers of polyoxaamides |
| 6110503, |
May 07 1996 |
ALKERMES, INC |
Preparation of biodegradable, biocompatible microparticles containing a biologically active agent |
| 6113938, |
Dec 30 1997 |
INTARCIA THERAPEUTICS, INC |
Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents |
| 6113947, |
Jun 13 1997 |
Genentech, Inc |
Controlled release microencapsulated NGF formulation |
| 6120787, |
Oct 19 1995 |
PACIRA PHARMACEUTICALS, INC |
Sustained release particles |
| 6124261, |
Jun 13 1997 |
HORATIO WASHINGTON DEPOT TECHNOLOGIES LLC |
Non-aqueous polar aprotic peptide formulations |
| 6124281, |
Mar 08 1996 |
AstraZeneca UK Limited |
Azolobenzazepine derivatives as neurologically active agents |
| 6127520, |
Apr 15 1997 |
REGENTS OF THE UNIVERSITY OF MICHIGAN, THE |
Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles |
| 6129761, |
Jun 07 1995 |
REPROGENESIS, INC |
Injectable hydrogel compositions |
| 6130200, |
Dec 20 1996 |
DURECT CORPORATION |
Gel composition and methods |
| 6132420, |
Feb 02 1996 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems |
| 6133249, |
Dec 19 1995 |
MacNaught Medical Pty Limited |
Phospholipid and propylene glycol based lubricant |
| 6133429, |
Oct 03 1997 |
Becton Dickinson and Company |
Chromophores useful for the preparation of novel tandem conjugates |
| 6146139, |
Jun 01 1999 |
|
Forceps apparatus |
| 6147168, |
Mar 06 1995 |
Ethicon, Inc. |
Copolymers of absorbable polyoxaesters |
| 6156331, |
Feb 02 1996 |
INTARCIA THERAPEUTICS, INC |
Sustained delivery of an active agent using an implantable system |
| 6172046, |
Sep 21 1997 |
Merck Sharp & Dohme Corp |
Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection |
| 6174547, |
Sep 09 1998 |
Encinal Pharmaceutical Investments, LLC |
Dosage form comprising liquid formulation |
| 6177096, |
Nov 11 1996 |
LTS Lohmann Therapie-Systeme AG |
Water soluble film for oral administration with instant wettability |
| 6183461, |
Mar 11 1998 |
SOLACE THERAPEUTICS, INC |
Method for delivering a medication |
| 6187095, |
Oct 31 1996 |
|
Process and apparatus for coating surgical sutures |
| 6190350, |
Dec 29 1997 |
INTARCIA THERAPEUTICS, INC |
Implanter device for subcutaneous implants |
| 6190700, |
Dec 15 1995 |
Takeda Pharmaceutical Company, Limited |
Production of sustained-release preparation for injection |
| 6190702, |
Mar 28 1996 |
Takeda Pharmaceutical Company, Limited |
Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase |
| 6191102, |
Nov 05 1996 |
Eli Lilly and Company |
Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity |
| 6204022, |
Apr 12 1996 |
University of Florida Research Foundation, Incorporated |
Low-toxicity human interferon-alpha analogs |
| 6217893, |
Apr 18 1997 |
Ipsen Pharma Biotech |
Sustained-release compositions and method for preparing same |
| 6217906, |
Mar 24 1997 |
INTARCIA THERAPEUTICS, INC |
Self adjustable exit port |
| 6217908, |
Apr 24 1992 |
PEROSPHERE INC |
Bioadhesive microspheres and their use as drug delivery and imaging systems |
| 6218431, |
Jul 31 1997 |
Bayer Pharmaceuticals Corporation |
Substituted biphenyls |
| 6224894, |
Mar 06 1995 |
Ethicon, Inc. |
Copolymers of absorbable polyoxaesters |
| 6235712, |
Jun 13 1997 |
HORATIO WASHINGTON DEPOT TECHNOLOGIES LLC |
Non-aqueous polar aprotic peptide formulations |
| 6245349, |
Feb 23 1996 |
ATHENA NEUROSCIENCES, INC |
Drug delivery compositions suitable for intravenous injection |
| 6245357, |
Mar 06 1998 |
ALZA Corporation |
Extended release dosage form |
| 6248112, |
Sep 30 1998 |
C R BARD, INC |
Implant delivery system |
| 6251435, |
Mar 06 1995 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides |
| 6258377, |
Jul 02 1996 |
Provalis UK Limited |
Hydrophobic preparations containing medium chain monoglycerides |
| 6261584, |
Feb 02 1996 |
INTARCIA THERAPEUTICS, INC |
Sustained delivery of an active agent using an implantable system |
| 6268343, |
Aug 30 1996 |
Novo Nordisk A S |
Derivatives of GLP-1 analogs |
| 6270700, |
Jul 23 1998 |
IPSEN PHARMA S A S |
Encapsulation of water soluble peptides |
| 6270787, |
Dec 29 1997 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system with membrane plug retention mechanism |
| 6277413, |
Jul 17 1998 |
PACIRA PHARMACEUTICALS, INC |
Biodegradable compositions for the controlled release of encapsulated substances |
| 6283949, |
Dec 27 1999 |
Advanced Cardiovascular Systems, INC |
Refillable implantable drug delivery pump |
| 6284264, |
Nov 11 1996 |
LTS Lohmann Therapie-Systeme GmbH |
Water soluble film for oral administration with instant wettability |
| 6284725, |
Oct 08 1998 |
AstraZeneca Pharmaceuticals LP |
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue |
| 6284727, |
Apr 07 1993 |
Scios INC |
Prolonged delivery of peptides |
| 6287295, |
Jul 25 1997 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system, osmotic delivery system semimpermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
| 6329336, |
May 17 1999 |
Conjuchem, LLC |
Long lasting insulinotropic peptides |
| 6331311, |
Dec 20 1996 |
DURECT CORPORATION |
Injectable depot gel composition and method of preparing the composition |
| 6372218, |
Nov 06 1986 |
The Texas A&M University System |
Interferon dosage form and method therefor |
| 6372256, |
Mar 06 1995 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides |
| 6375978, |
Dec 22 1997 |
INTARCIA THERAPEUTICS, INC |
Rate controlling membranes for controlled drug delivery devices |
| 6395282, |
Apr 16 1998 |
ROCHESTER, UNIVERSITY OF |
Immunogenic conjugates of Gram-negative bacterial autoinducer molecules |
| 6395292, |
Feb 02 1996 |
INTARCIA THERAPEUTICS, INC |
Sustained delivery of an active agent using an implantable system |
| 6402716, |
Feb 20 1998 |
LG Chemical Ltd. |
Syringe assembly |
| 6403655, |
Mar 06 1995 |
Ethicon, Inc |
Method of preventing adhesions with absorbable polyoxaesters |
| 6419952, |
Dec 17 1998 |
Encinal Pharmaceutical Investments, LLC |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings |
| 6428517, |
May 10 1999 |
CARDIAC SCIENCE, INC ; Milestone Scientific, Inc |
Hand-piece for injection device with a retractable and rotating needle |
| 6433144, |
Jan 12 1999 |
VIRAGEN, INC |
Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods |
| 6436091, |
Nov 16 1999 |
Microsolutions, Inc. |
Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
| 6447522, |
Sep 30 1998 |
C. R. Bard, Inc. |
Implant delivery system |
| 6451974, |
Mar 17 1999 |
Novo Nordisk A S |
Method of acylating peptides and novel acylating agents |
| 6458385, |
Mar 06 1995 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides |
| 6458387, |
Oct 18 1999 |
Baxter International Inc; BAXTER HEALTHCARE SA A CORPORATION OF SWITZERLAND |
Sustained release microspheres |
| 6458924, |
Aug 30 1996 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs |
| 6461605, |
Nov 02 1995 |
Merck Sharp & Dohme Corp |
Continuous low-dose cytokine infusion therapy |
| 6464688, |
Feb 15 2000 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment |
| 6468961, |
Dec 20 1996 |
DURECT CORPORATION |
Gel composition and methods |
| 6471688, |
Feb 15 2000 |
Microsolutions, Inc. |
Osmotic pump drug delivery systems and methods |
| 6472512, |
Jul 21 1998 |
Human Genome Sciences, INC |
Keratinocyte derived interferon |
| 6478768, |
Aug 08 1997 |
Gaplast GmbH |
Implant syringe |
| 6485706, |
Jun 04 1999 |
PATENT PROTECTION LEAGUE LLC |
Formulations comprising dehydrated particles of pharma-ceutical agents and process for preparing the same |
| 6495164, |
May 25 2000 |
Alkermes Pharma Ireland Limited |
Preparation of injectable suspensions having improved injectability |
| 6506724, |
Jun 01 1999 |
AstraZeneca Pharmaceuticals LP |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
| 6508808, |
Dec 21 1999 |
INTARCIA THERAPEUTICS, INC |
Valve for osmotic devices |
| 6514500, |
Oct 15 1999 |
Conjuchem, LLC |
Long lasting synthetic glucagon like peptide {GLP-!} |
| 6514517, |
Jun 20 2001 |
Ethicon, Inc |
Antimicrobial coatings for medical devices |
| 6524305, |
Jul 25 1997 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system flow modulator apparatus and method |
| 6528093, |
Dec 07 1992 |
Takeda Pharmaceutical Company, Limited |
Sustained-release preparation |
| 6528486, |
Jul 12 1999 |
ZP HOLDING SPV K S |
Peptide agonists of GLP-1 activity |
| 6541021, |
Mar 18 1999 |
DURECT CORPORATION |
Devices and methods for pain management |
| 6544239, |
Oct 16 1998 |
ICU MEDICAL SALES, INC |
Releasable locking needle assembly with optional release accessory therefor |
| 6544252, |
Dec 31 1998 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system having space efficient piston |
| 6547250, |
Aug 21 2000 |
WESTPORT POWER INC |
Seal assembly with two sealing mechanisms for providing static and dynamic sealing |
| 6551613, |
Sep 08 1998 |
Encinal Pharmaceutical Investments, LLC |
Dosage form comprising therapeutic formulation |
| 6569420, |
May 04 1998 |
Genentech, Inc. |
Human interferon-ε: a type I interferon |
| 6572890, |
Jan 13 2000 |
OSMOTICA KERESKEDELMI ÉS SZOLGÁLTATÓ KFT |
Osmotic device containing venlafaxine and an anti-psychotic agent |
| 6579851, |
Mar 14 2000 |
Amylin Pharmaceuticals, Inc |
Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| 6589157, |
May 18 2000 |
Integrated Implant Systems, L.L.C. |
Drive mechanism for medical instrument |
| 6592508, |
Dec 18 1995 |
INTEGRATED IMPLANT SYSTEMS, L L C |
Fiberoptic-guided interstitial seed manual applicator and seed cartridge |
| 6592887, |
Nov 11 1996 |
LTS Lohmann Therapie-Systeme AG |
Water soluble film for oral administration with instant wettability |
| 6593295, |
May 17 1999 |
Conjuchem, LLC |
Long lasting insulinotropic peptides |
| 6607529, |
Jun 19 1995 |
VIDAMED, INC |
Electrosurgical device |
| 6626863, |
Nov 22 2000 |
NUSAF, LLC |
Safety syringe |
| 6635268, |
Feb 02 1996 |
INTARCIA THERAPEUTICS, INC |
Sustained delivery of an active agent using an implantable system |
| 6645192, |
Sep 30 1998 |
Eli Lilly and Company |
Pellet implant system for immediate and delayed release of antiparasitic drug |
| 6667061, |
May 25 2000 |
Alkermes Pharma Ireland Limited |
Preparation of injectable suspensions having improved injectability |
| 6670368, |
Apr 06 1999 |
AstraZeneca AB |
Pyrimidine compounds with pharmaceutical activity |
| 6673767, |
Dec 20 1996 |
DURECT CORPORATION |
Gel composition and methods |
| 6682522, |
Dec 21 1999 |
INTARCIA THERAPEUTICS, INC |
Valve for osmotic devices |
| 6703225, |
Jan 12 1999 |
Sumitomo Pharmaceuticals Company, Limited |
Interferon-α |
| 6703359, |
Feb 13 1998 |
AstraZeneca Pharmaceuticals LP |
Inotropic and diuretic effects of exendin and GLP-1 |
| 6706689, |
May 19 2000 |
AstraZeneca Pharmaceuticals LP |
Treatment of acute coronary syndrome with GLP-1 |
| 6709671, |
Nov 11 1996 |
LTS Lohmann Therapie-Systeme AG |
Water soluble film for oral administration with instant wettability |
| 6720407, |
Aug 28 1998 |
Eli Lilly and Company |
Method for administering insulinotropic peptides |
| 6730328, |
Oct 16 1996 |
DURECT CORPORATION |
Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 6767887, |
Jun 05 1997 |
Roche Diagnostics GmbH |
Exendin analogues, processes for their preparation and medicaments containing them |
| 6821949, |
Oct 15 1999 |
Conjuchem, LLC |
Long lasting synthetic glucagon-like peptide (GLP-1) |
| 6833256, |
Jun 22 1999 |
University of Maryland |
Interferon tau mutants and methods for making them |
| 6835194, |
Mar 18 1999 |
DURECT CORPORATION |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
| 6840931, |
Jul 25 1997 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system flow modulator apparatus and method |
| 6849708, |
May 05 1986 |
The General Hospital Corporation |
Insulinotropic hormone and uses thereof |
| 6849714, |
May 17 1999 |
Conjuchem, LLC |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 6858576, |
Aug 08 1996 |
AstraZeneca Pharmaceuticals LP |
Methods for regulating gastrointestinal motility |
| 6872700, |
Jan 14 1999 |
AstraZeneca Pharmaceuticals LP |
Methods for glucagon suppression |
| 6875748, |
Apr 21 2000 |
Vical Incorporated |
Compositions and methods for in vivo delivery of polynucleotide-based therapeutics |
| 6887470, |
Sep 10 1999 |
Conjuchem, LLC |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 6887849, |
Oct 15 1999 |
Conjuchem, LLC |
Long lasting synthetic glucagon-like peptide {GLP-1} |
| 6899887, |
Dec 29 1997 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system with membrane plug retention mechanism |
| 6899898, |
Dec 21 2000 |
Alrise Biosystems GmbH |
Induced phase transition method for the production of microparticles containing hydrophobic active agents |
| 6902744, |
Jan 14 1999 |
AstraZeneca Pharmaceuticals LP |
Exendin agonist formulations and methods of administration thereof |
| 6903186, |
Dec 07 1998 |
IPSEN PHARMA S A S |
Analogues of GLP-1 |
| 6913767, |
Oct 25 1993 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines |
| 6923800, |
Jul 25 1997 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
| 6924264, |
Apr 30 1999 |
AstraZeneca Pharmaceuticals LP |
Modified exendins and exendin agonists |
| 6939556, |
Jun 26 2002 |
INTARCIA THERAPEUTICS, INC |
Minimally compliant, volume efficient piston for osmotic drug delivery systems |
| 6956026, |
Jan 07 1997 |
AstraZeneca Pharmaceuticals LP |
Use of exendins for the reduction of food intake |
| 6960192, |
Apr 23 2002 |
INSULET CORPORATION |
Transcutaneous fluid delivery system |
| 6969702, |
Nov 20 2002 |
NEWRON SWEDEN AB |
Compounds and methods for increasing neurogenesis |
| 6976981, |
Dec 29 1997 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system with membrane plug retention mechanism |
| 6989366, |
Jan 07 1997 |
AstraZeneca Pharmaceuticals LP |
Exendins, exendin agonists, and methods for their use |
| 6992065, |
Apr 19 2000 |
Genentech, Inc; DURECT CORPORATION |
Sustained release formulations |
| 6997922, |
Dec 13 1998 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system having space efficient piston |
| 7008439, |
Sep 21 1990 |
ST JUDE MEDICAL PUERTO RICO LLC |
Device and method for sealing puncture wounds |
| 7014636, |
Nov 21 2002 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel |
| 7022674, |
Dec 16 1999 |
Eli Lilly and Company |
Polypeptide compositions with improved stability |
| 7041646, |
Oct 05 2001 |
Bayer HealthCare LLC |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists |
| 7074423, |
Jun 17 2003 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery system with early zero order push power engine |
| 7084243, |
Jun 16 2000 |
Eli Lilly and Company |
Glucagon-like peptide-1 analogs |
| 7101567, |
May 29 1998 |
DAINIPPON SUMITOMO PHARMA CO , LTD |
Controlled release preparations having multi-layer structure |
| 7101843, |
Aug 23 2001 |
Eli Lilly and Company |
Glucagon-like peptide-1 analogs |
| 7112335, |
Jun 26 2002 |
INTARCIA THERAPEUTICS, INC |
Minimally compliant, volume-efficient piston for osmotic drug delivery systems |
| 7115569, |
Jan 07 1997 |
Amylin Pharmaceuticals, Inc |
Exendins, exendin agonists, and methods for their use |
| 7138375, |
Jan 07 1997 |
Amylin Pharmaceuticals, Inc |
Use of exendins and agonists thereof for lowering plasma lipid |
| 7138486, |
May 05 1986 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof |
| 7141547, |
Dec 21 2001 |
NOVOZYMES BIOPHARMA DK A S |
Albumin fusion proteins comprising GLP-1 polypeptides |
| 7144863, |
Jun 01 2001 |
Eli Lilly and Company |
GLP-1 formulations with protracted time action |
| 7153825, |
Dec 18 2001 |
Amylin Pharmaceuticals, Inc |
Methods for glucagon suppression using modified exendins |
| 7157555, |
Aug 08 1997 |
AstraZeneca Pharmaceuticals LP |
Exendin agonist compounds |
| 7163688, |
Jun 22 2001 |
INTARCIA THERAPEUTICS, INC |
Osmotic implant with membrane and membrane retention means |
| 7163697, |
Jun 22 2001 |
Johns Hopkins University School of Medicine |
Biodegradable polymer compositions, compositions and uses related thereto |
| 7199217, |
Dec 13 2000 |
Eli Lilly and Company |
Amidated glucagon-like peptide-1 |
| 7205409, |
Sep 04 2003 |
AbbVie Inc |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| 7207982, |
Mar 31 2003 |
INTARCIA THERAPEUTICS, INC |
Osmotic pump with means for dissipating internal pressure |
| 7214206, |
Apr 03 2003 |
ENDO PHARMACEUTICALS SOLUTIONS INC |
Implanting device and method of using same |
| 7241457, |
Sep 30 2003 |
INTARCIA THERAPEUTICS, INC |
Osmotically driven active agent delivery device providing an ascending release profile |
| 7258869, |
Feb 08 1999 |
INTARCIA THERAPEUTICS, INC |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
| 7297761, |
Aug 08 1996 |
AstraZeneca Pharmaceuticals LP |
Pharmaceutical compositions containing exendins |
| 7316680, |
Nov 21 2002 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel |
| 7393827, |
Dec 30 2004 |
DIAKINE THERAPEUTICS, INC |
Pharmaceutical compositions and methods for restoring β-cell mass and function |
| 7407499, |
Oct 31 2003 |
INTARCIA THERAPEUTICS, INC |
Osmotic pump with self-retaining, fast-start membrane plug |
| 7442682, |
Oct 19 2004 |
Nitto Denko Corporation |
Transepithelial delivery of peptides with incretin hormone activities |
| 7456254, |
Apr 15 2004 |
Alkermes Pharma Ireland Limited |
Polymer-based sustained release device |
| 7459432, |
Sep 24 2001 |
Imperial Innovations Limited |
Modification of feeding behavior |
| 7521423, |
Aug 08 1996 |
AstraZeneca Pharmaceuticals LP |
Exendin pharmaceutical compositions |
| 7563871, |
Apr 15 2004 |
Alkermes Pharma Ireland Limited |
Polymer-based sustained release device |
| 7589169, |
Feb 27 2002 |
PharmaIN Corporation |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| 7604647, |
Oct 22 2004 |
Medical Instrument Development Laboratories, Inc.; MEDICAL INSTRUMENT DEVELOPMENT LABORATORIES, INC |
Ophthalmic cannula insertion tool and method |
| 7612176, |
Apr 15 2004 |
Alkermes Pharma Ireland Limited |
Polymer-based sustained release device |
| 7632256, |
Oct 24 2006 |
HR PHARMACEUTICALS, INC ; Wiesman Holdings, LLC; HR PHARMECEUTICALS, INC |
Catheter gripping device |
| 7635463, |
Feb 27 2002 |
PharmaIN Corporation |
Compositions for delivery of therapeutics and other materials |
| 7655254, |
Feb 03 2005 |
INTARCIA THERAPEUTICS, INC |
Implantable device for continuous delivery of interferon |
| 7655257, |
Feb 02 1996 |
INTARCIA THERAPEUTICS, INC |
Sustained delivery of an active agent using an implantable system |
| 7666835, |
Sep 07 2001 |
Imperial Innovations Limited; IMPERIAL INNOVATIONS LIMTIED |
Oxyntomodulin for preventing or treating excess weight |
| 7682356, |
Aug 09 2006 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery systems and piston assemblies for use therein |
| 7727519, |
Nov 03 2000 |
Intarcia Therapeutics, Inc. |
Method for treating hepatitis C virus with omega interferon |
| 7731947, |
Nov 17 2003 |
INTARCIA THERAPEUTICS, INC |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| 7736665, |
May 31 2002 |
FEDSON, INC |
Implantable polymeric device for sustained release of buprenorphine |
| 7741269, |
Aug 08 1996 |
AstraZeneca Pharmaceuticals LP |
Exendins and exendin agonists for weight reduction and obesity |
| 7766924, |
Jul 28 1999 |
Aesculap AG |
System for performing anastomosis |
| 7790140, |
Feb 27 2002 |
PharmaIN Corporation |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
| 7825091, |
Jan 10 2003 |
Imperial Innovations Limited |
Modification of feeding behaviour |
| 7829109, |
Nov 14 2001 |
DURECT CORPORATION |
Catheter injectable depot compositions and uses thereof |
| 7833543, |
Jun 07 1995 |
DURECT CORPORATION |
High viscosity liquid controlled delivery system and medical or surgical device |
| 7879028, |
Aug 09 2006 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies for use therein |
| 7879794, |
Mar 31 2005 |
AstraZeneca Pharmaceuticals LP |
Methods for controlling binge eating disorders |
| 7919109, |
Feb 08 1999 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| 7928065, |
Feb 13 1998 |
Amylin Pharmaceuticals, Inc. |
Methods of treatment using exendin peptides or GLP-1 peptides |
| 7959938, |
Mar 15 2005 |
INTARCIA THERAPEUTICS, INC |
Polyoxaester suspending vehicles for use with implantable delivery systems |
| 7964183, |
Nov 17 2003 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising a particle formulation and suspending vehicle |
| 8039432, |
Nov 09 2005 |
Conjuchem, LLC |
Method of treatment of diabetes and/or obesity with reduced nausea side effect |
| 8048438, |
Feb 08 1999 |
Intarcia Therapeutics, Inc. |
Stable non- aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| 8052996, |
Feb 03 2005 |
INTARCIA THERAPEUTICS, INC |
Two-piece, internal-channel osmotic delivery system flow modulator |
| 8058233, |
Jan 10 2002 |
Imperial Innovations Limited |
Modification of feeding behavior using PYY and GLP-1 |
| 8101576, |
Dec 13 2006 |
Imperial Innovations Limited |
Compounds and their effects on feeding behaviour |
| 8114430, |
Mar 15 2005 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems |
| 8114437, |
Feb 03 2005 |
INTARCIA THERAPEUTICS, INC |
Solvent/polymer solutions as suspension vehicles |
| 8158150, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator |
| 8173150, |
Feb 08 1999 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles |
| 8202836, |
Mar 09 2005 |
Imperial Innovations Limited |
Modified PYY (3-36) peptides and their effects on feeding behavior |
| 8206745, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Solvent/polymer solutions as suspension vehicles |
| 8211467, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles |
| 8217001, |
Sep 24 2001 |
Oregon Health and Science University |
Modification of feeding behavior |
| 8231859, |
Feb 27 2002 |
PharmaIN Corporation |
Compositions for delivery of therapeutics and other materials |
| 8251946, |
Aug 24 2000 |
Cardiac Science Corporation |
Method for constructing an instrument with a two-part plunger for subcutaneous implantation |
| 8257682, |
Feb 27 2002 |
PharmaIN Corporation |
Compositions for delivery of therapeutics and other materials |
| 8257691, |
Nov 17 2003 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising a particle formulation and suspending vehicle |
| 8262667, |
Feb 23 2007 |
HOLMED, LLC |
Multi-diameter implant forceps |
| 8263545, |
Aug 17 2006 |
AstraZeneca Pharmaceuticals LP |
GIP analog and hybrid polypeptides with selectable properties |
| 8263736, |
Jul 03 2006 |
Imperial Innovations Limited |
Compounds and their effects on feeding behaviour |
| 8268341, |
Feb 08 1999 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| 8273365, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator |
| 8273713, |
Dec 14 2000 |
AstraZeneca Pharmaceuticals LP |
Methods of treating obesity using PYY[3-36] |
| 8277776, |
Feb 27 2002 |
PharmaIN Corporation |
Compositions for delivery of therapeutics and other materials |
| 8278267, |
Mar 31 2005 |
Amylin Pharmaceuticals, LLC |
Method of modifying food preference comprising administering amylin or amylin agonist |
| 8288338, |
Aug 08 1996 |
Amylin Pharmaceuticals, LLC |
Exendin and exendin agonists for eating disorders |
| 8298561, |
Sep 28 2009 |
INTARCIA THERAPEUTICS, INC |
Rapid establishment and/or termination of substantial steady-state drug delivery |
| 8299025, |
Feb 03 2005 |
INTARCIA THERAPEUTICS, INC |
Suspension formulations of insulinotropic peptides and uses thereof |
| 8343140, |
Feb 13 2008 |
INTARCIA THERAPEUTICS, INC |
Devices, formulations, and methods for delivery of multiple beneficial agents |
| 8367095, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator |
| 8372424, |
Feb 08 1999 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| 8398967, |
Dec 19 2002 |
INTARCIA THERAPEUTICS, INC |
Particle formulations for use in pharmaceutical compositions |
| 8440226, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Solvent/polymer solutions as suspension vehicles |
| 8454552, |
Aug 24 2000 |
Cardiac Science Corporation |
Method for constructing an instrument with a covered bore for subcutaneous implantation |
| 8460694, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Solvent/polymer solutions as suspension vehicles |
| 8470353, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator |
| 8722037, |
Mar 19 2004 |
MERCK SHARP & DOHME B V |
X-ray visible drug delivery device |
| 8747412, |
Feb 14 2011 |
ENGAGE MEDICAL HOLDINGS, LLC |
System and method for bone anchor removal |
| 8801700, |
Aug 09 2006 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies for use therein |
| 8815802, |
Dec 16 2009 |
Novo Nordisk A S |
GLP-1 analogues and derivatives |
| 8865202, |
Nov 11 1996 |
LTS Lohmann Therapie-Systeme AG |
Water soluble film for oral administration with instant wettability |
| 8888745, |
Jan 24 2005 |
MERCK SHARP & DOHME B V |
Applicator for inserting an implant |
| 8926595, |
Feb 13 2008 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents |
| 8940316, |
Feb 03 2005 |
INTARCIA THERAPEUTICS, INC |
Osmotic delivery comprising an insulinotropic peptide and uses thereof |
| 8992961, |
Feb 08 1999 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| 8992962, |
Feb 03 2005 |
Intarcia Therapeutics Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator |
| 9044209, |
Nov 25 2008 |
SOLACE THERAPEUTICS, INC |
Method of removing an inflated implant |
| 9078900, |
Sep 30 2008 |
BRAEBURN PHARMACEUTICALS, INC |
Implantable device for the delivery of risperidone and methods of use thereof |
| 9095553, |
Feb 03 2005 |
Intarcia Therapeutics Inc. |
Solvent/polymer solutions as suspension vehicles |
| 9526763, |
Feb 03 2005 |
Intarcia Therapeutics Inc. |
Solvent/polymer solutions as suspension vehicles |
| 9539200, |
Feb 03 2005 |
Intarcia Therapeutics Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator |
| 9572889, |
Feb 13 2008 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents |
| 9682127, |
Feb 03 2005 |
Intarcia Therapeutics, Inc. |
Osmotic delivery device comprising an insulinotropic peptide and uses thereof |
| 9889085, |
Sep 30 2014 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| 20010012511, |
|
|
|
| 20010021377, |
|
|
|
| 20010021822, |
|
|
|
| 20010022974, |
|
|
|
| 20010026793, |
|
|
|
| 20010027311, |
|
|
|
| 20010031790, |
|
|
|
| 20010031940, |
|
|
|
| 20010036472, |
|
|
|
| 20010040326, |
|
|
|
| 20020001631, |
|
|
|
| 20020004481, |
|
|
|
| 20020012818, |
|
|
|
| 20020034532, |
|
|
|
| 20020037309, |
|
|
|
| 20020048600, |
|
|
|
| 20020077599, |
|
|
|
| 20020098180, |
|
|
|
| 20020136848, |
|
|
|
| 20020137666, |
|
|
|
| 20020141985, |
|
|
|
| 20020197185, |
|
|
|
| 20020197235, |
|
|
|
| 20030007992, |
|
|
|
| 20030032947, |
|
|
|
| 20030040699, |
|
|
|
| 20030044467, |
|
|
|
| 20030045454, |
|
|
|
| 20030059376, |
|
|
|
| 20030059471, |
|
|
|
| 20030060425, |
|
|
|
| 20030078618, |
|
|
|
| 20030097121, |
|
|
|
| 20030104063, |
|
|
|
| 20030108608, |
|
|
|
| 20030108609, |
|
|
|
| 20030113380, |
|
|
|
| 20030114837, |
|
|
|
| 20030118660, |
|
|
|
| 20030135153, |
|
|
|
| 20030138403, |
|
|
|
| 20030138491, |
|
|
|
| 20030157178, |
|
|
|
| 20030170289, |
|
|
|
| 20030180364, |
|
|
|
| 20030186858, |
|
|
|
| 20030191099, |
|
|
|
| 20030211974, |
|
|
|
| 20030215515, |
|
|
|
| 20030220617, |
|
|
|
| 20030233101, |
|
|
|
| 20040001689, |
|
|
|
| 20040001889, |
|
|
|
| 20040002442, |
|
|
|
| 20040022859, |
|
|
|
| 20040024068, |
|
|
|
| 20040024069, |
|
|
|
| 20040029784, |
|
|
|
| 20040039376, |
|
|
|
| 20040047888, |
|
|
|
| 20040097906, |
|
|
|
| 20040101557, |
|
|
|
| 20040102762, |
|
|
|
| 20040115236, |
|
|
|
| 20040142867, |
|
|
|
| 20040142902, |
|
|
|
| 20040151753, |
|
|
|
| 20040157951, |
|
|
|
| 20040198654, |
|
|
|
| 20040199140, |
|
|
|
| 20040209801, |
|
|
|
| 20040215133, |
|
|
|
| 20040224903, |
|
|
|
| 20040225113, |
|
|
|
| 20040243106, |
|
|
|
| 20040265273, |
|
|
|
| 20040266683, |
|
|
|
| 20040266692, |
|
|
|
| 20050004557, |
|
|
|
| 20050008661, |
|
|
|
| 20050009742, |
|
|
|
| 20050010196, |
|
|
|
| 20050010942, |
|
|
|
| 20050070883, |
|
|
|
| 20050070927, |
|
|
|
| 20050079200, |
|
|
|
| 20050079202, |
|
|
|
| 20050095284, |
|
|
|
| 20050101943, |
|
|
|
| 20050106214, |
|
|
|
| 20050112188, |
|
|
|
| 20050118206, |
|
|
|
| 20050118221, |
|
|
|
| 20050131386, |
|
|
|
| 20050131389, |
|
|
|
| 20050143749, |
|
|
|
| 20050175701, |
|
|
|
| 20050201980, |
|
|
|
| 20050215475, |
|
|
|
| 20050216087, |
|
|
|
| 20050266087, |
|
|
|
| 20050271702, |
|
|
|
| 20050276856, |
|
|
|
| 20050281879, |
|
|
|
| 20060013879, |
|
|
|
| 20060014678, |
|
|
|
| 20060030526, |
|
|
|
| 20060069029, |
|
|
|
| 20060073182, |
|
|
|
| 20060084604, |
|
|
|
| 20060084922, |
|
|
|
| 20060094652, |
|
|
|
| 20060094693, |
|
|
|
| 20060106399, |
|
|
|
| 20060141040, |
|
|
|
| 20060142234, |
|
|
|
| 20060160736, |
|
|
|
| 20060178304, |
|
|
|
| 20060193918, |
|
|
|
| 20060216242, |
|
|
|
| 20060224145, |
|
|
|
| 20060233841, |
|
|
|
| 20060246138, |
|
|
|
| 20060251618, |
|
|
|
| 20060263433, |
|
|
|
| 20060264890, |
|
|
|
| 20060280795, |
|
|
|
| 20060293232, |
|
|
|
| 20070027105, |
|
|
|
| 20070141102, |
|
|
|
| 20070149011, |
|
|
|
| 20070166352, |
|
|
|
| 20070207958, |
|
|
|
| 20070248572, |
|
|
|
| 20070281024, |
|
|
|
| 20080020016, |
|
|
|
| 20080038316, |
|
|
|
| 20080064636, |
|
|
|
| 20080065090, |
|
|
|
| 20080091176, |
|
|
|
| 20080110515, |
|
|
|
| 20080112994, |
|
|
|
| 20080200383, |
|
|
|
| 20080207512, |
|
|
|
| 20080226625, |
|
|
|
| 20080226689, |
|
|
|
| 20080260838, |
|
|
|
| 20080260840, |
|
|
|
| 20080269725, |
|
|
|
| 20080312157, |
|
|
|
| 20090012463, |
|
|
|
| 20090022727, |
|
|
|
| 20090036364, |
|
|
|
| 20090042781, |
|
|
|
| 20090074734, |
|
|
|
| 20090087408, |
|
|
|
| 20090156474, |
|
|
|
| 20090163447, |
|
|
|
| 20090186817, |
|
|
|
| 20090202481, |
|
|
|
| 20090202608, |
|
|
|
| 20090209460, |
|
|
|
| 20090210019, |
|
|
|
| 20090215694, |
|
|
|
| 20090247463, |
|
|
|
| 20090254143, |
|
|
|
| 20090286723, |
|
|
|
| 20090312246, |
|
|
|
| 20100092566, |
|
|
|
| 20100094252, |
|
|
|
| 20100105627, |
|
|
|
| 20100144621, |
|
|
|
| 20100185184, |
|
|
|
| 20100297209, |
|
|
|
| 20100298807, |
|
|
|
| 20100298840, |
|
|
|
| 20100331868, |
|
|
|
| 20110076317, |
|
|
|
| 20110091527, |
|
|
|
| 20110104111, |
|
|
|
| 20110152181, |
|
|
|
| 20110152182, |
|
|
|
| 20110160708, |
|
|
|
| 20110166554, |
|
|
|
| 20110264077, |
|
|
|
| 20110306549, |
|
|
|
| 20120178687, |
|
|
|
| 20120208755, |
|
|
|
| 20120303045, |
|
|
|
| 20130030417, |
|
|
|
| 20130034210, |
|
|
|
| 20130052237, |
|
|
|
| 20130296661, |
|
|
|
| 20130324977, |
|
|
|
| 20140058409, |
|
|
|
| 20140058425, |
|
|
|
| 20140121741, |
|
|
|
| 20140163057, |
|
|
|
| 20140236162, |
|
|
|
| 20140257272, |
|
|
|
| 20140324067, |
|
|
|
| 20140378900, |
|
|
|
| 20150001118, |
|
|
|
| 20150057227, |
|
|
|
| 20150111818, |
|
|
|
| 20150133791, |
|
|
|
| 20150231062, |
|
|
|
| 20150231256, |
|
|
|
| 20150297509, |
|
|
|
| 20150359553, |
|
|
|
| 20160022582, |
|
|
|
| 20160030337, |
|
|
|
| 20160354115, |
|
|
|
| 20160354305, |
|
|
|
| 20170056476, |
|
|
|
| 20170079906, |
|
|
|
| 20170119854, |
|
|
|
| 20170119855, |
|
|
|
| 20170181964, |
|
|
|
| 20170252409, |
|
|
|
| 20170319470, |
|
|
|
| 20170319662, |
|
|
|
| 20170348392, |
|
|
|
| 20170368145, |
|
|
|
| 20180009871, |
|
|
|
| D430671, |
May 10 1999 |
SHUTE, CHRISTOPHER W |
Obstetrical forceps |
| D565179, |
Jun 16 2005 |
PENTAX Corporation; Shinichiro, Kubo |
Bone implant |
| D789539, |
Jul 09 2015 |
Spinal Surgical Strategies, LLC |
Fusion cage |
| D816843, |
Jun 07 2017 |
ALEVIO, LLC |
Orthopedic implant |
| D835783, |
Jun 02 2016 |
Intarcia Therapeutics, Inc. |
Implant placement guide |
| D840030, |
Jun 02 2016 |
INTARCIA THERAPEUTICS INC |
Implant placement guide |
| DE635692, |
|
|
|
| EP79405, |
|
|
|
| EP254394, |
|
|
|
| EP295411, |
|
|
|
| EP304107, |
|
|
|
| EP368339, |
|
|
|
| EP373867, |
|
|
|
| EP379147, |
|
|
|
| EP431942, |
|
|
|
| EP486959, |
|
|
|
| EP497575, |
|
|
|
| EP521586, |
|
|
|
| EP596161, |
|
|
|
| EP627231, |
|
|
|
| EP631794, |
|
|
|
| EP729747, |
|
|
|
| EP767689, |
|
|
|
| EP771817, |
|
|
|
| EP841359, |
|
|
|
| EP1046399, |
|
|
|
| EP1084703, |
|
|
|
| EP1300129, |
|
|
|
| EP1300173, |
|
|
|
| EP1323450, |
|
|
|
| EP1600187, |
|
|
|
| EP2020990, |
|
|
|
| EP2133073, |
|
|
|
| FR2616665, |
|
|
|
| FR640907, |
|
|
|
| GB1049104, |
|
|
|
| GB1518683, |
|
|
|
| GB2138298, |
|
|
|
| GB2501400, |
|
|
|
| JP11100353, |
|
|
|
| JP1997509346, |
|
|
|
| JP2006213727, |
|
|
|
| JP2124814, |
|
|
|
| JP7196479, |
|
|
|
| JP9241153, |
|
|
|
| NL8901004, |
|
|
|
| NL9000948, |
|
|
|
| NL9100160, |
|
|
|
| NZ592113, |
|
|
|
| TW200634060, |
|
|
|
| WO13663, |
|
|
|
| WO29206, |
|
|
|
| WO38652, |
|
|
|
| WO39280, |
|
|
|
| WO40273, |
|
|
|
| WO41548, |
|
|
|
| WO45790, |
|
|
|
| WO54745, |
|
|
|
| WO66138, |
|
|
|
| WO67728, |
|
|
|
| WO1043528, |
|
|
|
| WO1051041, |
|
|
|
| WO128631, |
|
|
|
| WO168168, |
|
|
|
| WO178683, |
|
|
|
| WO2028366, |
|
|
|
| WO2036072, |
|
|
|
| WO2043800, |
|
|
|
| WO2045752, |
|
|
|
| WO2067895, |
|
|
|
| WO2069983, |
|
|
|
| WO2085428, |
|
|
|
| WO247716, |
|
|
|
| WO276344, |
|
|
|
| WO3000230, |
|
|
|
| WO3007981, |
|
|
|
| WO3011892, |
|
|
|
| WO3024357, |
|
|
|
| WO3024503, |
|
|
|
| WO3030923, |
|
|
|
| WO3041684, |
|
|
|
| WO3041757, |
|
|
|
| WO3053400, |
|
|
|
| WO3072113, |
|
|
|
| WO3072133, |
|
|
|
| WO4002565, |
|
|
|
| WO4046338, |
|
|
|
| WO4052336, |
|
|
|
| WO4056338, |
|
|
|
| WO4089335, |
|
|
|
| WO5048930, |
|
|
|
| WO5048952, |
|
|
|
| WO5102293, |
|
|
|
| WO6017772, |
|
|
|
| WO6023526, |
|
|
|
| WO6081279, |
|
|
|
| WO6083761, |
|
|
|
| WO6084139, |
|
|
|
| WO6086727, |
|
|
|
| WO6101815, |
|
|
|
| WO6111169, |
|
|
|
| WO7024700, |
|
|
|
| WO7056681, |
|
|
|
| WO7075534, |
|
|
|
| WO7084460, |
|
|
|
| WO7133778, |
|
|
|
| WO7140416, |
|
|
|
| WO8021133, |
|
|
|
| WO8061355, |
|
|
|
| WO8133908, |
|
|
|
| WO8134425, |
|
|
|
| WO9109927, |
|
|
|
| WO1989003678, |
|
|
|
| WO1990013285, |
|
|
|
| WO1990013361, |
|
|
|
| WO1990013780, |
|
|
|
| WO1992019241, |
|
|
|
| WO1994010982, |
|
|
|
| WO1995013799, |
|
|
|
| WO1996036317, |
|
|
|
| WO1996040049, |
|
|
|
| WO1997031943, |
|
|
|
| WO1997041837, |
|
|
|
| WO1997044039, |
|
|
|
| WO1998007412, |
|
|
|
| WO1998030231, |
|
|
|
| WO199813091, |
|
|
|
| WO1999012549, |
|
|
|
| WO2000059476, |
|
|
|
| WO2000066087, |
|
|
|
| WO2001019345, |
|
|
|
| WO2001028525, |
|
|
|
| WO2003020245, |
|
|
|
| WO2003066585, |
|
|
|
| WO2004026106, |
|
|
|
| WO2004034975, |
|
|
|
| WO2004035754, |
|
|
|
| WO2004035762, |
|
|
|
| WO2004036186, |
|
|
|
| WO2004089458, |
|
|
|
| WO2004103342, |
|
|
|
| WO2005102293, |
|
|
|
| WO2005110425, |
|
|
|
| WO2006077242, |
|
|
|
| WO2006077250, |
|
|
|
| WO2006131730, |
|
|
|
| WO2007082889, |
|
|
|
| WO2008041245, |
|
|
|
| WO2008086086, |
|
|
|
| WO2009143285, |
|
|
|
| WO2010045169, |
|
|
|
| WO2013004983, |
|
|
|
| WO2013184235, |
|
|
|
| WO9107160, |
|
|
|
| WO93008832, |
|
|
|
| WO9306819, |
|
|
|
| WO9306821, |
|
|
|
| WO9309763, |
|
|
|
| WO9323083, |
|
|
|
| WO9409743, |
|
|
|
| WO9421262, |
|
|
|
| WO9501167, |
|
|
|
| WO9509006, |
|
|
|
| WO9509007, |
|
|
|
| WO9534285, |
|
|
|
| WO96001134, |
|
|
|
| WO96003116, |
|
|
|
| WO9639142, |
|
|
|
| WO9640049, |
|
|
|
| WO9640139, |
|
|
|
| WO9640355, |
|
|
|
| WO9715289, |
|
|
|
| WO9715296, |
|
|
|
| WO9728181, |
|
|
|
| WO9746204, |
|
|
|
| WO9747339, |
|
|
|
| WO9800152, |
|
|
|
| WO9800157, |
|
|
|
| WO9800158, |
|
|
|
| WO9802169, |
|
|
|
| WO98027962, |
|
|
|
| WO98030231, |
|
|
|
| WO9813092, |
|
|
|
| WO9816250, |
|
|
|
| WO9817315, |
|
|
|
| WO9820930, |
|
|
|
| WO9827960, |
|
|
|
| WO9827963, |
|
|
|
| WO9832463, |
|
|
|
| WO9842317, |
|
|
|
| WO9847487, |
|
|
|
| WO9851282, |
|
|
|
| WO9858698, |
|
|
|
| WO99004768, |
|
|
|
| WO99025728, |
|
|
|
| WO99033446, |
|
|
|
| WO9903453, |
|
|
|
| WO99040788, |
|
|
|
| WO99044659, |
|
|
|
| WO9904767, |
|
|
|
| WO99062501, |
|
|
|
| WO99064061, |
|
|
|
| WO9916419, |
|
|
|
| WO9929306, |
|
|
|
| WO9933449, |
|
|
|
| WO9939700, |
|
|
|